These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11818173)

  • 1. Evaluation of a salivary based combined dexamethasone/CRH test in patients with major depression.
    Baghai TC; Schüle C; Zwanzger P; Minov C; Holme C; Padberg F; Bidlingmaier M; Strasburger CJ; Rupprecht R
    Psychoneuroendocrinology; 2002 Apr; 27(3):385-99. PubMed ID: 11818173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study.
    Zobel AW; Nickel T; Sonntag A; Uhr M; Holsboer F; Ising M
    J Psychiatr Res; 2001; 35(2):83-94. PubMed ID: 11377437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?
    Ising M; Horstmann S; Kloiber S; Lucae S; Binder EB; Kern N; Künzel HE; Pfennig A; Uhr M; Holsboer F
    Biol Psychiatry; 2007 Jul; 62(1):47-54. PubMed ID: 17123470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dexamethasone/corticotropin-releasing hormone test in depression in bipolar and unipolar affective illness.
    Rybakowski JK; Twardowska K
    J Psychiatr Res; 1999; 33(5):363-70. PubMed ID: 10504004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combined dexamethasone/CRH Test (DEX/CRH test) and prediction of acute treatment response in major depression.
    Schüle C; Baghai TC; Eser D; Häfner S; Born C; Herrmann S; Rupprecht R
    PLoS One; 2009; 4(1):e4324. PubMed ID: 19177168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothalamic-pituitary-adrenocortical axis dysregulation in patients with major depression is influenced by the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene.
    Baghai TC; Schule C; Zwanzger P; Minov C; Zill P; Ella R; Eser D; Oezer S; Bondy B; Rupprecht R
    Neurosci Lett; 2002 Aug; 328(3):299-303. PubMed ID: 12147330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.
    Schüle C; Baghai TC; Eser D; Zwanzger P; Jordan M; Buechs R; Rupprecht R
    Psychopharmacology (Berl); 2006 Jul; 186(4):601-11. PubMed ID: 16758243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T; Otsubo T; Oshima A; Nakagome K; Higuchi T; Kamijima K
    Psychoneuroendocrinology; 2008 Feb; 33(2):152-61. PubMed ID: 18068306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder.
    Watson S; Gallagher P; Ritchie JC; Ferrier IN; Young AH
    Br J Psychiatry; 2004 Jun; 184():496-502. PubMed ID: 15172943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
    Künzel HE; Binder EB; Nickel T; Ising M; Fuchs B; Majer M; Pfennig A; Ernst G; Kern N; Schmid DA; Uhr M; Holsboer F; Modell S
    Neuropsychopharmacology; 2003 Dec; 28(12):2169-78. PubMed ID: 12931142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients.
    Schüle C; Baghai T; Zwanzger P; Minov C; Padberg F; Rupprecht R
    J Psychiatr Res; 2001; 35(4):239-47. PubMed ID: 11578642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoids and relapse of major depression (dexamethasone/corticotropin-releasing hormone test in relation to relapse of major depression).
    Appelhof BC; Huyser J; Verweij M; Brouwer JP; van Dyck R; Fliers E; Hoogendijk WJ; Tijssen JG; Wiersinga WM; Schene AH
    Biol Psychiatry; 2006 Apr; 59(8):696-701. PubMed ID: 16368077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time-dependent effects of dexamethasone plasma concentrations on glucocorticoid receptor challenge tests.
    Menke A; Arloth J; Best J; Namendorf C; Gerlach T; Czamara D; Lucae S; Dunlop BW; Crowe TM; Garlow SJ; Nemeroff CB; Ritchie JC; Craighead WE; Mayberg HS; Rex-Haffner M; Binder EB; Uhr M
    Psychoneuroendocrinology; 2016 Jul; 69():161-71. PubMed ID: 27107207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic-pituitary-adrenal axis function in patients with chronic depression.
    Watson S; Gallagher P; Del-Estal D; Hearn A; Ferrier IN; Young AH
    Psychol Med; 2002 Aug; 32(6):1021-8. PubMed ID: 12214783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.
    Kunugi H; Ida I; Owashi T; Kimura M; Inoue Y; Nakagawa S; Yabana T; Urushibara T; Kanai R; Aihara M; Yuuki N; Otsubo T; Oshima A; Kudo K; Inoue T; Kitaichi Y; Shirakawa O; Isogawa K; Nagayama H; Kamijima K; Nanko S; Kanba S; Higuchi T; Mikuni M
    Neuropsychopharmacology; 2006 Jan; 31(1):212-20. PubMed ID: 16123748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between response to lithium augmentation and the combined DEX/CRH test in major depressive disorder.
    Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Modell S; Künzel H; Müller-Oerlinghausen B; Bauer M
    J Psychiatr Res; 2003; 37(2):135-43. PubMed ID: 12842167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB; Künzel HE; Nickel T; Kern N; Pfennig A; Majer M; Uhr M; Ising M; Holsboer F
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressive effect of mirtazapine on the HPA system in acutely depressed women seems to be transient and not related to antidepressant action.
    Horstmann S; Dose T; Lucae S; Kloiber S; Menke A; Hennings J; Spieler D; Uhr M; Holsboer F; Ising M
    Psychoneuroendocrinology; 2009 Feb; 34(2):238-248. PubMed ID: 18926641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lithium monotherapy increases ACTH and cortisol response in the DEX/CRH test in unipolar depressed subjects. A study with 30 treatment-naive patients.
    Bschor T; Ritter D; Winkelmann P; Erbe S; Uhr M; Ising M; Lewitzka U
    PLoS One; 2011; 6(11):e27613. PubMed ID: 22132117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C; Vermetten E; Lentjes E; Geuze E; van Pelt J; Manuel R; Heijnen C; Westenberg H
    Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.